4
Changes in Ownership
Amphastar Pharmaceuticals, Inc. Filed Acc 0001104659-20-003034
President and General Counsel sold 25,000 shares at $18.44 ($460,978)
- President and General Counsel acquired 25,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shandell Jason B. President and General Counsel | 2020-01-08 | Option exercise | +25,000 | $10.93 | $273,250 | 163,898 | D |
| Shandell Jason B. President and General Counsel | 2020-01-08 | Sale | −25,000 | $18.44 | $460,978 | 138,898 | D |
| Derivatives | |||||||
| Shandell Jason B. President and General Counsel | 2020-01-08 | Option exercise · Employee Stock Option (right to buy) | −25,000 | 9,149 | D | ||
| Open-market sales · 25,000 sh · avg $18.44 · $460,978 | |||||||
Loading xslF345X03/a4.xml…